Phagenesis: Funding, Investors & Team (Sep 2026)
Phagenesis is working on a device to treat dysphagia, the inability to swallow safely, often seen in stroke or other neuro-deficit diseases. The focus is on utilizing the brain's ability to relearn lost functions through neuroplasticity or cortical remapping. Professor Shaheen Hamdy from the University of Manchester developed a method to send electrical signals from the pharynx to the brain, with promising results published in respected scientific and medical journals like The Lancet and Nature group.
Phagenesis has raised $42.0M across 2 funding rounds on record, the most recent an undisclosed round of $42.0M announced in Mar 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phagenesis Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Phagenesis Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Phagenesis announced a Non-equity Assistance in Jun 2022; the amount was not disclosed.
1.8 years later, an undisclosed round of $42.0M was announced in Mar 2024.
Phagenesis Founders and Leadership Team
Contact details for the Phagenesis team: 1 of 1 has an email address on file.
Start 14-day free trial →Phagenesis Funding Compared to Other Biotechnology Startups
Phagenesis' latest round of $42.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phagenesis in Biotechnology and Manchester
Companies Similar to Phagenesis
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Phagenesis Funding FAQs
What does Phagenesis do?
Phagenesis is working on a device to treat dysphagia, the inability to swallow safely, often seen in stroke or other neuro-deficit diseases. The focus is on utilizing the brain's ability to relearn lost functions through neuroplasticity or cortical remapping. Professor Shaheen Hamdy from the University of Manchester developed a method to send electrical signals from the pharynx to the brain, with promising results published in respected scientific and medical journals like The Lancet and Nature group.
How much funding has Phagenesis raised?
Phagenesis has raised $42.0M across 2 rounds on record. The most recent is an undisclosed round of $42.0M announced in Mar 2024.
When did Phagenesis last raise funding?
Phagenesis' most recent funding round on record is an undisclosed round of $42.0M, announced in Mar 2024.
Who founded Phagenesis?
FundedIQ lists Conor Mulrooney (Founder) at Phagenesis.
Where is Phagenesis headquartered?
Phagenesis is based in Manchester, United Kingdom.
How many employees does Phagenesis have?
Phagenesis is in the 11-50 employee band.
How does Phagenesis' funding compare to other Biotechnology startups?
Phagenesis' latest round of $42.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Phagenesis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phagenesis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.